Fluidity-One-W-Serum

Introducing Fluidity One-W Serum

Fight COVID-19 via accurate immune response assessment in minimally diluted serum

Antibodies-to-cell movement-of-the-virus

Sign up for our latest webinar

Measuring What Really Matters: Safe, Rapid and Variant-Specific Affinity-Based Virus-Neutralization Assays

Scientist-using-a-microscope

Understand the machinery of life

We envision a world where information about protein interactions transforms our understanding of how the biological world operates

COVID-19-Coronavirus-cell-pandemic-virus

Our latest application note

Accurate solution phase affinity profiling of a SARS-CoV-2 antibody in serum

Introducing Fluidity One-W Serum

Sign up for our latest webinar

Our company vision

Our latest application note

Built on Peer Reviewed Science

The technology underlying our instruments has been featured in a number of high impact, peer-reviewed journals.

Publication


Our technology reveals the differences in the antibody affinity and stoichiometry for four clinical stage anti-Aβ drug candidates to treat Alzheimer’s Disease

Publication


Clinical researchers discover the spectrum of antibody affinity from plasma of COVID-patients using our technology

Publication


Microfluidic diffusional sizing helps elucidate the specificity and selectivity of designed antibodies against Aβ oligomers

A full list of all the papers showing the research behind Fluidic Analytics and microfluidic diffusional sizing (MDS) can be found here. As well as seeing where others have used our products to make amazing discoveries. 

All Publications

Fluidic Analytics is changing how proteins are characterised

We're doing this with novel, cutting edge technology and a fantastic, committed team

Find out more